Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Kekkaku : [Tuberculosis]|September 1, 2005
[A case of pulmonary Mycobacterium scrofulaceum infection presented as pleurisy]Hisae Fusegawa, Yasuyuki Ookubo, Mai Nishiumi, et al.
Springerplus|February 20, 2013
Skin rash by gefitinib is a sign of favorable outcomes for patients of advanced lung adenocarcinoma in Japanese patientsYasoo Sugiura, Etsuo Nemoto, Osamu Kawai, et al.
Lung Cancer (Auckland, N.Z.)|February 18, 2017
Gefitinib frequently induces liver damage in patients with lung adenocarcinoma previously treated by chemotherapyYasoo Sugiura, Etsuo Nemoto, Osamu Kawai, et al.
The Tokai Journal of Experimental and Clinical Medicine|June 15, 2005
Platelet activation in patients with alcoholic liver diseaseFusao Ogasawara, Hisae Fusegawa, Yasuo Haruki, et al.
Kansenshogaku Zasshi. the Journal of the Japanese Association for Infectious Diseases|April 24, 2003
Outbreak of tuberculosis in a 2000-year-old Chinese populationHisae Fusegawa, Bing-Hua Wang, Kiyohiko Sakurai, et al.
Kekkaku : [Tuberculosis]|September 20, 2008
[Epidemiological study on factors affecting the hospitalization period of patients with active tuberculosis]Tadahiko Fujino, Hisae Fusegawa, Mai Nishiumi, et al.
The Tokai Journal of Experimental and Clinical Medicine|April 26, 2003
Platelet activation in patients with chronic hepatitis CHisae Fusegawa, Koichi Shiraishi, Fusao Ogasawara, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|October 16, 2015
[Complete Remission after Weekly Intravenous Nanoparticle Albumin-Bound Paclitaxel in Elderly Patients with Non-Small-Cell Lung Cancer]Yasoo Sugiura, Toshinori Hashizume, Osamu Kawai, et al.
General Thoracic and Cardiovascular Surgery|March 31, 2023
An independent prognostic factor in surgical cases of pleural empyema caused by common bacteria is the presence of a fistulaYasoo Sugiura, Morio Nakamura, Hiroyuki Fujimoto, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|September 16, 2017
[Psoriasis and Psoriatic Arthritis Induced by Nivolumab in a Patient with Advanced Non-Small-Cell Lung Cancer]Yasoo Sugiura, Hiroyuki Fujimoto, Munehiro Yamamoto, et al.
Pageof 1